Jonathan Glanzman
Papers
1
Total Citations
9
H-Index
1
About
Jonathan Glanzman is a surgical oncologist whose research focuses on refining treatment strategies for head and neck squamous cell carcinoma, with a particular emphasis on the interplay between transoral robotic surgery (TORS) and adjuvant therapies. His most cited work, a 2013 study, critically examines the risk of retropharyngeal node (RPN) recurrence in patients undergoing TORS. Glanzman’s major contribution lies in demonstrating that the absence of adjuvant radiotherapy following TORS may significantly elevate the risk of RPN recurrence, a finding that challenges the assumption that minimally invasive surgery alone is sufficient for disease control. This insight has direct implications for clinical decision-making, urging careful consideration of postoperative radiation to improve patient outcomes. With 9 citations, his work has informed discussions on multimodal treatment protocols, highlighting the need to address nodal basins not directly accessed by TORS. Glanzman’s research underscores the importance of integrating surgical and radiotherapeutic approaches, making him a key voice in optimizing head and neck cancer care. His findings continue to guide clinicians in balancing the benefits of robotic surgery with the necessity of comprehensive adjuvant management.
Research Focus
Key Achievements
Top Papers
- 1